Literature DB >> 15713410

Crystal structures of human HSP90alpha-complexed with dihydroxyphenylpyrazoles.

Andreas Kreusch1, Shulin Han, Achim Brinker, Vicki Zhou, Ha-soon Choi, Yun He, Scott A Lesley, Jeremy Caldwell, Xiang-ju Gu.   

Abstract

A series of dihydroxyphenylpyrazole compounds were identified as a unique class of reversible Hsp90 inhibitors. The crystal structures for two of the identified compounds complexed with the N-terminal ATP binding domain of human Hsp90alpha were determined. The dihydroxyphenyl ring of the compounds fits deeply into the adenine binding pocket with the C2 hydroxyl group forming a direct hydrogen bond with the side chain of Asp93. The pyrazole ring forms hydrogen bonds to the backbone carbonyl of Gly97, the hydroxyl group of Thr184 and to a water molecule, which is present in all of the published HSP90 structures. One of the identified compounds (G3130) demonstrated cellular activities (in Her-2 degradation and activation of Hsp70 promoter) consistent with the inhibition of cellular Hsp90 functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713410     DOI: 10.1016/j.bmcl.2004.12.087

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

Review 1.  Heat shock proteins as emerging therapeutic targets.

Authors:  Csaba Sõti; Enikõ Nagy; Zoltán Giricz; László Vígh; Péter Csermely; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 2.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

3.  Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.

Authors:  Nanette L S Que; Vincent M Crowley; Adam S Duerfeldt; Jinbo Zhao; Caitlin N Kent; Brian S J Blagg; Daniel T Gewirth
Journal:  J Med Chem       Date:  2018-03-20       Impact factor: 7.446

4.  Synthesis of 2-(2,4-dihydroxyphenyl)thieno-1,3-thiazin-4-ones, their lipophilicity and anticancer activity in vitro.

Authors:  Joanna Matysiak; Małgorzata Juszczak; Monika M Karpińska; Ewa Langner; Katarzyna Walczak; Marta K Lemieszek; Alicja Skrzypek; Andrzej Niewiadomy; Wojciech Rzeski
Journal:  Mol Divers       Date:  2015-04-29       Impact factor: 2.943

5.  Role of heat shock proteins in diseases and their therapeutic potential.

Authors:  Gautam Kaul; Hitesh Thippeswamy
Journal:  Indian J Microbiol       Date:  2011-02-09       Impact factor: 2.461

6.  Discovery of aminoquinolines as a new class of potent inhibitors of heat shock protein 90 (Hsp90): Synthesis, biology, and molecular modeling.

Authors:  Thota Ganesh; Jaeki Min; Pahk Thepchatri; Yuhong Du; Lian Li; Iestyn Lewis; Larry Wilson; Haian Fu; Gabriela Chiosis; Raymond Dingledine; Dennis Liotta; James P Snyder; Aiming Sun
Journal:  Bioorg Med Chem       Date:  2008-05-27       Impact factor: 3.641

Review 7.  Discovery and development of heat shock protein 90 inhibitors.

Authors:  Tony Taldone; Weilin Sun; Gabriela Chiosis
Journal:  Bioorg Med Chem       Date:  2008-11-06       Impact factor: 3.641

8.  Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design.

Authors:  Robert M Immormino; Louis E Metzger; Patrick N Reardon; D Eric Dollins; Brian S J Blagg; Daniel T Gewirth
Journal:  J Mol Biol       Date:  2009-04-08       Impact factor: 5.469

9.  Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects.

Authors:  Kyle P Smith; Kathleen M Gifford; Joshua S Waitzman; Sarah E Rice
Journal:  Proteins       Date:  2014-11-18

Review 10.  Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future.

Authors:  Daniel T Gewirth
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.